Insider · CIK 0001691102
Christopher Yea
officer
Files at KALV (KalVista Pharmaceuticals, Inc.). First filing Nov 19, 2024, latest Nov 26, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 13
$0 bought, $875k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | KalVista Pharmaceuticals, Inc. | $58k 4,331 shares | -2% | - | |
| 21Weak | KalVista Pharmaceuticals, Inc. | $39k 2,683 shares | -2% | - | |
| 20Weak | KalVista Pharmaceuticals, Inc. | $26k 1,954 shares | -1% | - | |
| 20Weak | KalVista Pharmaceuticals, Inc. | $31k 2,362 shares | -2% | - | |
| 21Weak | KalVista Pharmaceuticals, Inc. | $35k 2,649 shares | -2% | - | |
| 45Moderate | KalVista Pharmaceuticals, Inc. | $475k 30,250 shares | -19% | - | |
| 15Weak | KalVista Pharmaceuticals, Inc. | $22k 1,926 shares | -2% | - | |
| 20Weak | KalVista Pharmaceuticals, Inc. | $28k 2,317 shares | -2% | - | |
| 20Weak | KalVista Pharmaceuticals, Inc. | $31k 2,600 shares | -3% | - | |
| 15Weak | KalVista Pharmaceuticals, Inc. | $19k 1,918 shares | -2% | - | |
| 20Weak | KalVista Pharmaceuticals, Inc. | $26k 2,601 shares | -3% | - | |
| 15Weak | KalVista Pharmaceuticals, Inc. | $19k 1,963 shares | -2% | - | |
| 23Weak | KalVista Pharmaceuticals, Inc. | $67k 7,192 shares | -7% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +3,750 | - | - | 224,714 | Nov 26, 2025 |
| Nov 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +3,125 | - | - | 227,839 | Nov 26, 2025 |
| Nov 24, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -4,331 | $13.45 | $58k | 223,508 | Nov 26, 2025 |
| Nov 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -3,750 | $0.00 | $0 | 48,750 | Nov 26, 2025 |
| Nov 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -3,125 | $0.00 | $0 | 31,250 | Nov 26, 2025 |
| Nov 20, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +87,390 | $0.00 | $376 | 220,964 | Nov 21, 2025 |
| Nov 20, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -87,390 | $0.00 | $0 | 0 | Nov 21, 2025 |
| Nov 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +4,205 | - | - | 136,257 | Nov 19, 2025 |
| Nov 18, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -2,683 | $14.48 | $39k | 133,574 | Nov 19, 2025 |
| Nov 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -1,774 | $0.00 | $0 | 3,548 | Nov 19, 2025 |
| Nov 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -2,431 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Aug 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +3,125 | - | - | 134,006 | Aug 26, 2025 |
| Aug 25, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -1,954 | $13.42 | $26k | 132,052 | Aug 26, 2025 |
| Aug 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -3,125 | $0.00 | $0 | 34,375 | Aug 26, 2025 |
| Aug 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +3,750 | - | - | 133,243 | Aug 25, 2025 |
| Aug 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -2,362 | $13.22 | $31k | 130,881 | Aug 25, 2025 |
| Aug 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -3,750 | $0.00 | $0 | 52,500 | Aug 25, 2025 |
| Aug 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +4,203 | - | - | 132,142 | Aug 19, 2025 |
| Aug 18, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -2,649 | $13.19 | $35k | 129,493 | Aug 19, 2025 |
| Aug 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -1,773 | $0.00 | $0 | 5,322 | Aug 19, 2025 |
| Aug 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -2,430 | $0.00 | $0 | 2,431 | Aug 19, 2025 |
| Jul 8, 2025 | KALV KalVista Pharmaceuticals, Inc. | AGrant or award Common Stock | +60,000 | - | - | 158,189 | Jul 10, 2025 |
| Jul 9, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -30,250 | $15.69 | $475k | 127,939 | Jul 10, 2025 |
| May 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +3,125 | - | - | 100,115 | May 27, 2025 |
| May 23, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -1,926 | $11.31 | $22k | 98,189 | May 27, 2025 |
| May 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -3,125 | $0.00 | $0 | 37,500 | May 27, 2025 |
| May 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +3,750 | - | - | 99,307 | May 23, 2025 |
| May 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -2,317 | $11.88 | $28k | 96,990 | May 23, 2025 |
| May 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -3,750 | $0.00 | $0 | 56,250 | May 23, 2025 |
| May 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +4,205 | - | - | 98,157 | May 20, 2025 |
| May 19, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -2,600 | $11.84 | $31k | 95,557 | May 20, 2025 |
| May 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -1,774 | $0.00 | $0 | 7,095 | May 20, 2025 |
| May 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -2,431 | $0.00 | $0 | 4,861 | May 20, 2025 |
| Feb 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +3,125 | - | - | 95,870 | Feb 25, 2025 |
| Feb 24, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -1,918 | $10.02 | $19k | 93,952 | Feb 25, 2025 |
| Feb 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitderivative | +60,000 | $0.00 | $0 | 60,000 | Feb 25, 2025 |
| Feb 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -3,125 | $0.00 | $0 | 40,625 | Feb 25, 2025 |
| Feb 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +4,204 | - | - | 95,346 | Feb 19, 2025 |
| Feb 18, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -2,601 | $9.82 | $26k | 92,745 | Feb 19, 2025 |
| Feb 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -1,774 | $0.00 | $0 | 8,869 | Feb 19, 2025 |
| Feb 17, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -2,430 | $0.00 | $0 | 7,292 | Feb 19, 2025 |
| Nov 22, 2024 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +3,125 | - | - | 93,105 | Nov 27, 2024 |
| Nov 26, 2024 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -1,963 | $9.87 | $19k | 91,142 | Nov 27, 2024 |
| Nov 22, 2024 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -3,125 | $0.00 | $0 | 43,750 | Nov 27, 2024 |
| Nov 17, 2024 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +11,496 | - | - | 97,172 | Nov 19, 2024 |
| Nov 18, 2024 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -7,192 | $9.26 | $67k | 89,980 | Nov 19, 2024 |
| Nov 17, 2024 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -1,774 | $0.00 | $0 | 10,643 | Nov 19, 2024 |
| Nov 17, 2024 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -2,431 | $0.00 | $0 | 9,722 | Nov 19, 2024 |
| Nov 17, 2024 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Performance Stock Unitsderivative | -7,291 | $0.00 | $0 | 0 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.